ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) P/E Ratio

Adaptive Biotechnologies Corp PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

• Adaptive Biotechnologies Corp pe ratio for the quarter ending 2026-06-30 was -53.43, a change of -38.81 year-over-year.
• Adaptive Biotechnologies Corp pe ratio for the quarter ending 2026-03-31 was -44.63, a change of -36.68 year-over-year.
• Adaptive Biotechnologies Corp pe ratio for the quarter ending 2025-12-31 was -41.95, a change of -36.39 year-over-year.
• Adaptive Biotechnologies Corp pe ratio for the quarter ending 2025-09-30 was -28.69, a change of -24.82 year-over-year.
• Adaptive Biotechnologies Corp pe ratio for fiscal 2026 was -53.43.
• Adaptive Biotechnologies Corp pe ratio for fiscal 2025 was -41.95, a change of -36.39 from fiscal 2024.
• Adaptive Biotechnologies Corp pe ratio for fiscal 2024 was -5.55, a change of -2.4 from fiscal 2023.
• Adaptive Biotechnologies Corp pe ratio for fiscal 2023 was -3.16, a change of 2.31 from fiscal 2022.